A Phase II, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Study to Evaluate the Efficacy and Safety of JYB1904 Injection Combined With Background Therapy in Patients With Perennial Allergic Rhinitis
Latest Information Update: 13 Mar 2026
At a glance
- Drugs Ozureprubart (Primary)
- Indications Perennial allergic rhinitis
- Focus Therapeutic Use
- Sponsors Jemincare
Most Recent Events
- 13 Mar 2026 New trial record